New understanding of brain chemistry could prevent brain damage after injury
May 15, 2011 in Medical research
A protective molecule has been identified in the brain which, if used artificially, may prevent brain damage from the likes of stroke, head injury and Alzheimer's.
By looking at what happens in the brain after an injury, new research has finally ended speculation over whether a key molecule, 'KCC2' causes brain cell death after an injury or prevents it. The finding, published today (16th May 2011) in The Journal of Physiology now opens the door to the development of artificial forms of the compound which could provide 'neuroprotection' to those who have suffered a brain injury to prevent further damage.
Lead author of the research Dr Igor Medina from the Universite de la Mediterranee said: "Neuron damage can result from acute events such as stroke, epilepsy or head injury or by chronic degeneration found in Alzheimer's and Parkinson's.
"When brain tissue is damaged, cells often continue to die after the initial stimulus has stopped. So it is important to find a way of stopping this cascade of cell death."
KCC2 is known as a 'neuronal membrane transporter' and plays a valuable role in regulating brain cell growth and their connections with other neurons. Previous research has shown that the level of KCC2 drops drastically after the brain has been injured, but it was unknown whether this drop was causing the damage to the cells, or was decreasing because of it.
"The destiny of neurons in a damaged brain depends on a tiny equilibrium between pro-survival and pro-death signals. We wanted to know what KCC2 was signalling for was it killing neurons or protecting them after an injury? Our study has found that KCC2 actually rescues the damaged cells."
The team studied damaged neurons from the hippocampus region of the brain, an area responsible for attention, spatial memory and navigation. They removed KCC2 altogether from damaged cells and found they died. But when they artificially increased the levels of KCC2 (by stimulating its expression using gene therapy), they found the damaged cells were protected from further damage, and death.
Dr Medina continued: "The death of neurons in the brain can be triggered by an imbalance of oxygen known as oxidative damage, or where cells are incorrectly instructed to die by a neurotransmitter a process known as excitotoxicity. KCC2 protects against both. It's really encouraging that we have identified a means of potentially protecting the brain from these common conditions."
Now the protective function of KCC2 is known, scientists can look at ways to maintain its levels in the brains of injured patients and prevent the cascade of damage that occurs. This could be achieved pharmaceutically, to naturally increase the levels of KCC2, or with gene therapy to introduce artificial KCC2.
"Neuroprotective agents that may stem from this research would benefit the victims of car crashes, stroke and those suffering with epilepsy, Parkinson's and Alzheimer's it's a major focus for further studies," concluded Dr Medina.
More information: Knocking down of the KCC2 in rat hippocampal neurons increases intracellular chloride concentration and compromises neuronal survival. Christophe Pellegrino, Olena Gubkina, Michael Schaefer, H´el`ene Becq, Anastasia Ludwig, Marat Mukhtarov, Ilona Chudotvorova, Severine Corby, Yuriy Salyha, Sergey Salozhin, Piotr Bregestovski and Igor Medina. .J Physiol 589, 2475-2496.
Provided by
Wiley
-
How brain injury leads to seizures, memory problems
Oct 18, 2006 |
not rated yet |
0
-
Researchers find explanation for rapid maturation of neurons at birth
Nov 17, 2009 |
not rated yet |
0
-
Matrix fragments trigger fatal excitement
Dec 29, 2008 |
not rated yet |
0
-
Specific protein may help neurons fix themselves in Parkinson's patients
Jul 22, 2010 |
not rated yet |
0
-
Researchers identify novel mechanism to reduce nervous system inflammation
Sep 24, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Computational tool translates complex data into simplified 2-dimensional images
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
Medical research
13 hours ago |
5 / 5 (3) |
0
|
Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research
May 17, 2013 |
4 / 5 (4) |
0
|
SUMO wrestling cells reveal new protective mechanism target for stroke
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research
May 17, 2013 |
5 / 5 (1) |
0
How serotonin receptors can shape drug effects, from LSD to migraine medication
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research
May 17, 2013 |
4 / 5 (1) |
0
|
Preventing blood poisoning
Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.
Medical research
May 17, 2013 |
4 / 5 (1) |
0
|
Blame your parents for bunion woes
A novel study reports that white men and women of European descent inherit common foot disorders, such as bunions (hallux valgus) and lesser toe deformities, including hammer or claw toe. Findings from the Framingham Foot ...
Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak
Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.
Commonly used catheters double risk of blood clots in ICU and cancer patients
Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.
Molecular marker from pancreatic 'juices' helps identify pancreatic cancer
Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis—two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic ...
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Researchers identify a potential new risk for sleep apnea: Asthma
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...